Harnessing genomics to improve outcomes for women with cancer in India: key priorities for research

Sudha Sundar, Poonam Khetrapal-Singh, Jon Frampton, Edward Trimble, Preetha Rajaraman, Ravi Mehrotra, Roopa Hariprasad, Arindam Maitra, Paramjit Gill, Vanita Suri, Radhika Srinivasan, Gurpreet Singh, J. S. Thakur, Preet Dhillon, Jean Baptiste Cazier

Research output: Contribution to journalReview article

Abstract

Cumulatively, breast, cervical, ovarian, and uterine cancer account for more than 70% of cancers in women in India. Distinct differences in the clinical presentation of women with cancer suggest underlying differences in cancer biology and genetics. The peak age of onset of breast and ovarian cancer appears to be a decade earlier in India (age 45–50 years) than in high-income countries (age >60 years). Understanding these differences through research to develop diagnosis, screening, prevention, and treatment frameworks that ar e specific to the Indian population are critical and essential to improving women's health in India. Since the sequencing of the human genome in 2001, applications of advanced technologies, such as massively parallel sequencing, have transformed the understanding of the genetic and environmental drivers of cancer. How can advanced technologies be harnessed to provide health-care solutions at a scale and to a budget suitable for a country of 1·2 billion people? What research programmes are necessary to answer questions specific to India, and to build capacity for innovative solutions using these technologies? In order to answer these questions, we convened a workshop with key stakeholders to address these issues. In this Series paper, we highlight challenges in tackling the growing cancer burden in India, discuss ongoing genomics research and developments in infrastructure, and suggest key priorities for future research in cancer in India.

Original languageEnglish (US)
Pages (from-to)e102-e112
JournalThe Lancet Oncology
Volume19
Issue number2
DOIs
StatePublished - Feb 1 2018
Externally publishedYes

Fingerprint

Genomics
India
Research
Neoplasms
Technology
Ovarian Neoplasms
Breast Neoplasms
High-Throughput Nucleotide Sequencing
Women's Health
Human Genome
Budgets
Age of Onset
Uterine Cervical Neoplasms
Delivery of Health Care
Education
Population

ASJC Scopus subject areas

  • Oncology

Cite this

Sundar, S., Khetrapal-Singh, P., Frampton, J., Trimble, E., Rajaraman, P., Mehrotra, R., ... Cazier, J. B. (2018). Harnessing genomics to improve outcomes for women with cancer in India: key priorities for research. The Lancet Oncology, 19(2), e102-e112. https://doi.org/10.1016/S1470-2045(17)30726-X

Harnessing genomics to improve outcomes for women with cancer in India : key priorities for research. / Sundar, Sudha; Khetrapal-Singh, Poonam; Frampton, Jon; Trimble, Edward; Rajaraman, Preetha; Mehrotra, Ravi; Hariprasad, Roopa; Maitra, Arindam; Gill, Paramjit; Suri, Vanita; Srinivasan, Radhika; Singh, Gurpreet; Thakur, J. S.; Dhillon, Preet; Cazier, Jean Baptiste.

In: The Lancet Oncology, Vol. 19, No. 2, 01.02.2018, p. e102-e112.

Research output: Contribution to journalReview article

Sundar, S, Khetrapal-Singh, P, Frampton, J, Trimble, E, Rajaraman, P, Mehrotra, R, Hariprasad, R, Maitra, A, Gill, P, Suri, V, Srinivasan, R, Singh, G, Thakur, JS, Dhillon, P & Cazier, JB 2018, 'Harnessing genomics to improve outcomes for women with cancer in India: key priorities for research', The Lancet Oncology, vol. 19, no. 2, pp. e102-e112. https://doi.org/10.1016/S1470-2045(17)30726-X
Sundar, Sudha ; Khetrapal-Singh, Poonam ; Frampton, Jon ; Trimble, Edward ; Rajaraman, Preetha ; Mehrotra, Ravi ; Hariprasad, Roopa ; Maitra, Arindam ; Gill, Paramjit ; Suri, Vanita ; Srinivasan, Radhika ; Singh, Gurpreet ; Thakur, J. S. ; Dhillon, Preet ; Cazier, Jean Baptiste. / Harnessing genomics to improve outcomes for women with cancer in India : key priorities for research. In: The Lancet Oncology. 2018 ; Vol. 19, No. 2. pp. e102-e112.
@article{69aac2acb51e401bbaa72cabeb2e9f2b,
title = "Harnessing genomics to improve outcomes for women with cancer in India: key priorities for research",
abstract = "Cumulatively, breast, cervical, ovarian, and uterine cancer account for more than 70{\%} of cancers in women in India. Distinct differences in the clinical presentation of women with cancer suggest underlying differences in cancer biology and genetics. The peak age of onset of breast and ovarian cancer appears to be a decade earlier in India (age 45–50 years) than in high-income countries (age >60 years). Understanding these differences through research to develop diagnosis, screening, prevention, and treatment frameworks that ar e specific to the Indian population are critical and essential to improving women's health in India. Since the sequencing of the human genome in 2001, applications of advanced technologies, such as massively parallel sequencing, have transformed the understanding of the genetic and environmental drivers of cancer. How can advanced technologies be harnessed to provide health-care solutions at a scale and to a budget suitable for a country of 1·2 billion people? What research programmes are necessary to answer questions specific to India, and to build capacity for innovative solutions using these technologies? In order to answer these questions, we convened a workshop with key stakeholders to address these issues. In this Series paper, we highlight challenges in tackling the growing cancer burden in India, discuss ongoing genomics research and developments in infrastructure, and suggest key priorities for future research in cancer in India.",
author = "Sudha Sundar and Poonam Khetrapal-Singh and Jon Frampton and Edward Trimble and Preetha Rajaraman and Ravi Mehrotra and Roopa Hariprasad and Arindam Maitra and Paramjit Gill and Vanita Suri and Radhika Srinivasan and Gurpreet Singh and Thakur, {J. S.} and Preet Dhillon and Cazier, {Jean Baptiste}",
year = "2018",
month = "2",
day = "1",
doi = "10.1016/S1470-2045(17)30726-X",
language = "English (US)",
volume = "19",
pages = "e102--e112",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "2",

}

TY - JOUR

T1 - Harnessing genomics to improve outcomes for women with cancer in India

T2 - key priorities for research

AU - Sundar, Sudha

AU - Khetrapal-Singh, Poonam

AU - Frampton, Jon

AU - Trimble, Edward

AU - Rajaraman, Preetha

AU - Mehrotra, Ravi

AU - Hariprasad, Roopa

AU - Maitra, Arindam

AU - Gill, Paramjit

AU - Suri, Vanita

AU - Srinivasan, Radhika

AU - Singh, Gurpreet

AU - Thakur, J. S.

AU - Dhillon, Preet

AU - Cazier, Jean Baptiste

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Cumulatively, breast, cervical, ovarian, and uterine cancer account for more than 70% of cancers in women in India. Distinct differences in the clinical presentation of women with cancer suggest underlying differences in cancer biology and genetics. The peak age of onset of breast and ovarian cancer appears to be a decade earlier in India (age 45–50 years) than in high-income countries (age >60 years). Understanding these differences through research to develop diagnosis, screening, prevention, and treatment frameworks that ar e specific to the Indian population are critical and essential to improving women's health in India. Since the sequencing of the human genome in 2001, applications of advanced technologies, such as massively parallel sequencing, have transformed the understanding of the genetic and environmental drivers of cancer. How can advanced technologies be harnessed to provide health-care solutions at a scale and to a budget suitable for a country of 1·2 billion people? What research programmes are necessary to answer questions specific to India, and to build capacity for innovative solutions using these technologies? In order to answer these questions, we convened a workshop with key stakeholders to address these issues. In this Series paper, we highlight challenges in tackling the growing cancer burden in India, discuss ongoing genomics research and developments in infrastructure, and suggest key priorities for future research in cancer in India.

AB - Cumulatively, breast, cervical, ovarian, and uterine cancer account for more than 70% of cancers in women in India. Distinct differences in the clinical presentation of women with cancer suggest underlying differences in cancer biology and genetics. The peak age of onset of breast and ovarian cancer appears to be a decade earlier in India (age 45–50 years) than in high-income countries (age >60 years). Understanding these differences through research to develop diagnosis, screening, prevention, and treatment frameworks that ar e specific to the Indian population are critical and essential to improving women's health in India. Since the sequencing of the human genome in 2001, applications of advanced technologies, such as massively parallel sequencing, have transformed the understanding of the genetic and environmental drivers of cancer. How can advanced technologies be harnessed to provide health-care solutions at a scale and to a budget suitable for a country of 1·2 billion people? What research programmes are necessary to answer questions specific to India, and to build capacity for innovative solutions using these technologies? In order to answer these questions, we convened a workshop with key stakeholders to address these issues. In this Series paper, we highlight challenges in tackling the growing cancer burden in India, discuss ongoing genomics research and developments in infrastructure, and suggest key priorities for future research in cancer in India.

UR - http://www.scopus.com/inward/record.url?scp=85044394262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044394262&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(17)30726-X

DO - 10.1016/S1470-2045(17)30726-X

M3 - Review article

C2 - 29413464

AN - SCOPUS:85044394262

VL - 19

SP - e102-e112

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 2

ER -